Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).
Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, visits the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO).